What does CUSIP 92243G108 represent in this 13F holders report?

CUSIP 92243G108 is the security identifier for PCVX - Vaxcyte, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

How many institutions held PCVX - Vaxcyte, Inc. - Common Stock, $0.001 par value per share in Q3 2020?

60 institutional investors reported PCVX - Vaxcyte, Inc. - Common Stock, $0.001 par value per share for Q3 2020. Use the holders table for investor-level position and value details.

Vaxcyte, Inc. - Common Stock, $0.001 par value per share (PCVX)

CUSIP: 92243G108

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 145,782,011
Total 13F shares: 37,761,937
Share change: +1,811,105
Total reported value: $1,857,382,730
Price per share: $49.38
Number of holders: 60
Value change: +$103,777,823
Number of buys: 41
Number of sells: 23

Quarterly Holders Quick Answers

What is CUSIP 92243G108?
CUSIP 92243G108 identifies PCVX - Vaxcyte, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2020
Previous quarter: Q2 2020

Recent filing periods for CUSIP 92243G108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PCVX - Vaxcyte, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RA CAPITAL MANAGEMENT, L.P.	13F	Company	3.8%	5,489,181	$173,513,000	—	30 Jun 2020	13F
TPG Group Holdings (SBS) Advisors, Inc.	13F	Company	3.5%	5,156,553	$162,999,000	—	30 Jun 2020	13F
FMR LLC	13F	Company	3.2%	4,706,759	$148,780,000	—	30 Jun 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	3.2%	4,725,792	$139,934,000	—	30 Jun 2020	13F
Abingworth LLP	13F	Company	2.9%	4,168,718	$131,523,000	—	30 Jun 2020	13F
FRAZIER MANAGEMENT LLC	13F	Company	1.6%	2,309,554	$73,005,000	—	30 Jun 2020	13F
Medicxi Ventures Management (Jersey) Ltd	13F	Company	1.3%	1,887,478	$59,663,000	—	30 Jun 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.82%	1,200,000	$37,932,000	—	30 Jun 2020	13F
Novo Holdings A/S	13F	Company	0.6%	881,898	$27,877,000	—	30 Jun 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.6%	868,318	$27,448,000	—	30 Jun 2020	13F
ORBIMED ADVISORS LLC	13F	Company	0.58%	850,000	$26,869,000	—	30 Jun 2020	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.58%	850,000	$26,869,000	—	30 Jun 2020	13F
Foresite Capital Management IV, LLC	13F	Company	0.43%	620,821	$19,624,000	—	30 Jun 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.38%	549,751	$17,377,000	—	30 Jun 2020	13F
Logos Global Management LP	13F	Company	0.31%	455,000	$14,383,000	—	30 Jun 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.27%	400,070	$12,694,000	—	30 Jun 2020	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.14%	206,322	$6,522,000	—	30 Jun 2020	13F
Ikarian Capital, LLC	13F	Company	0.1%	139,813	$4,419,000	—	30 Jun 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.06%	87,424	$2,763,000	—	30 Jun 2020	13F
Monashee Investment Management LLC	13F	Company	0.05%	80,000	$2,529,000	—	30 Jun 2020	13F
BlackRock Finance, Inc.	13F	Company	0.05%	79,812	$2,523,000	—	30 Jun 2020	13F
Marshall Wace North America L.P.	13F	Company	0.03%	38,856	$1,228,000	—	30 Jun 2020	13F
VANGUARD GROUP INC	13F	Company	0.02%	30,000	$948,000	—	30 Jun 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.02%	25,526	$806,000	—	30 Jun 2020	13F
Woodline Partners LP	13F	Company	0.02%	23,026	$728,000	—	30 Jun 2020	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0.01%	20,000	$632,000	—	30 Jun 2020	13F
NORGES BANK	13F	Company	0.01%	20,000	$632,000	—	30 Jun 2020	13F
Pinz Capital Management, LP	13F	Company	0.01%	20,000	$632,000	—	30 Jun 2020	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.01%	17,637	$558,000	—	30 Jun 2020	13F
JANE STREET GROUP, LLC	13F	Company	0.01%	13,380	$423,000	—	30 Jun 2020	13F
Point72 Hong Kong Ltd	13F	Company	0.01%	7,716	$244,000	—	30 Jun 2020	13F
Crestline Management, LP	13F	Company	0%	7,000	$221,000	—	30 Jun 2020	13F
Pentwater Capital Management LP	13F	Company	0%	7,000	$221,000	—	30 Jun 2020	13F
Endurant Capital Management LP	13F	Company	0%	6,827	$216,000	—	30 Jun 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	200	$6,000	—	30 Jun 2020	13F
ROYAL BANK OF CANADA	13F	Company	0%	200	$6,000	—	30 Jun 2020	13F
MORGAN STANLEY	13F	Company	0%	100	$3,000	—	30 Jun 2020	13F
Sowell Financial Services LLC	13F	Company	0%	100	$3,000	—	30 Jun 2020	13F

Institutional Holders of Vaxcyte, Inc. - Common Stock, $0.001 par value per share (PCVX) as of Q3 2020

As of 30 Sep 2020, Vaxcyte, Inc. - Common Stock, $0.001 par value per share (PCVX) was held by 60 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 37,761,937 shares. The largest 10 holders included FMR LLC, RA CAPITAL MANAGEMENT, L.P., TPG Group Holdings (SBS) Advisors, Inc., JANUS HENDERSON GROUP PLC, Abingworth LLP, FRAZIER MANAGEMENT LLC, Medicxi Ventures Management (Jersey) Ltd, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, and BlackRock Inc.. This page lists 60 institutional shareholders reporting positions in this security for the Q3 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders

Q3 2020 holders

Holder diff

Investor	Q2 2020 Shares	Q3 2020 Shares	Share Diff	Share Chg %	Q2 2020 Value $	Q3 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.